| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/06/2013 | US8501800 Controlled-release ophthalmic vehicles |
| 08/06/2013 | US8501717 Methods to treat and/or prevent mucositis |
| 08/06/2013 | US8501697 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 08/06/2013 | US8501696 Soluble GP130 muteins with improved binding activity |
| 08/06/2013 | US8501695 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 08/06/2013 | US8501694 Method of administering porcine B-domainless fVIII |
| 08/06/2013 | US8501693 Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen |
| 08/06/2013 | US8501692 Compositions and methods for altering cocaine esterase activity |
| 08/06/2013 | US8501691 Methods for treatment of headaches by administration of oxytocin |
| 08/06/2013 | US8501690 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue |
| 08/06/2013 | US8501689 Growth factor-mimicking peptides and uses thereof |
| 08/06/2013 | US8501688 SCGB3A2 as a growth factor and anti-apoptotic agent |
| 08/06/2013 | US8501687 Receptor(SSTR2)-selective somatostatin antagonists |
| 08/06/2013 | US8501686 Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects |
| 08/06/2013 | US8501685 Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products |
| 08/06/2013 | US8501683 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 08/06/2013 | US8501682 Difluorinated tripeptides as HCV serine protease inhibitors |
| 08/06/2013 | US8501680 Antagonists against interaction of PF4 and RANTES |
| 08/06/2013 | US8501679 Cyclic, cystein-free protein |
| 08/06/2013 | US8501678 Variant activin receptor polypeptides and uses thereof |
| 08/06/2013 | US8501677 Methods and compositions for modulating T cell and/or B cell activation |
| 08/06/2013 | US8501676 Preparation for use of aspartate for regulating glucose levels in blood |
| 08/06/2013 | US8501473 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 08/06/2013 | US8501449 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 08/06/2013 | US8501440 Fibrillation-resistant insulin and insulin analogues |
| 08/06/2013 | US8501439 Method for obtaining active pro-NGF and beta-NGF |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | US8501223 Methods for dietary management of cats to avoid hyperthyroidism |
| 08/06/2013 | US8501205 Insect repellent composition |
| 08/06/2013 | US8501197 Compositions and methods for stimulating immune response against Moraxella catarrhalis |
| 08/06/2013 | US8501196 Pharmaceutical compositions containing botulinum neurotoxin |
| 08/06/2013 | US8501193 Stabilized Tat antigen and the use thereof for anti-HIV vaccination |
| 08/06/2013 | US8501192 Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis |
| 08/06/2013 | US8501189 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 08/06/2013 | US8501187 Stabilized biodegradable neurotoxin implants |
| 08/06/2013 | US8501177 Treatment of ectodermal dysplasia with EDA1 fusion proteins |
| 08/06/2013 | US8501174 Prevention and treatment of ocular side effects with a cyclosporin |
| 08/06/2013 | US8501173 Antibodies to high mobility group-1(HMGB1) B-box polypeptides |
| 08/06/2013 | US8501166 Pyrimidinyl indole compounds |
| 08/06/2013 | US8501089 Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes |
| 08/06/2013 | CA2714081C Methods and compositions for treating conditions of the eye |
| 08/06/2013 | CA2672907C Pegylated pth as pth receptor modulators and uses thereof |
| 08/06/2013 | CA2582462C Prion protein binding materials and methods of use |
| 08/06/2013 | CA2564179C Biologically active peptide vapeehptllteaplnpk derivatives |
| 08/06/2013 | CA2557304C Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 08/06/2013 | CA2532473C Amino acid supplementation for a healthy microbiota ecosystem |
| 08/06/2013 | CA2529660C Vegf traps and therapeutic uses thereof |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2451839C Pharmaceutical compositions comprising peptides and permeation enhancers |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2391415C Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 08/06/2013 | CA2388807C Viruses for the treatment of cellular proliferative disorders |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/01/2013 | WO2013113030A2 Fads regulation |
| 08/01/2013 | WO2013113024A1 Lyophilized platelet lysates |
| 08/01/2013 | WO2013112942A1 Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| 08/01/2013 | WO2013112912A1 Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use |
| 08/01/2013 | WO2013112871A1 Therapeutic il-13 polypeptides |
| 08/01/2013 | WO2013112663A1 Myonectin (ctrp15), compositions comprising same, and methods of use |
| 08/01/2013 | WO2013112548A1 Gamma-aapeptides with potent and broad-spectrum antimicrobial activity |
| 08/01/2013 | WO2013112456A1 Controlled release formulations for the induction and proliferation of blood cells |
| 08/01/2013 | WO2013111129A1 Stabilized peptide helices for inhibiting dimerization of chemokine c motif receptor 2 (ccr2) |
| 08/01/2013 | WO2013110749A1 Therapeutic use of activators of zinc finger protein gli3 |
| 08/01/2013 | WO2013110621A1 Stabilised protein compositions based on semifluorinated alkanes |
| 08/01/2013 | WO2013110471A1 Means for endotoxin detoxification |
| 08/01/2013 | WO2013110354A1 Compositions and methods for cell transplantation |
| 08/01/2013 | WO2013110163A1 Compositions and methods of modulating an immune response |
| 08/01/2013 | WO2013110121A1 Assay for a biomarker of a central nervous system disorder |
| 08/01/2013 | WO2013110120A1 Peptide agents for cancer therapy |
| 08/01/2013 | WO2013083858A9 Compounds suitable for treatment of haemophilia |
| 08/01/2013 | WO2013083826A3 Glp-1 agonists |
| 08/01/2013 | WO2013082531A3 Broad spectrum influenza a neutralizing vaccines and d-peptidic compounds, and methods for making and using the same |
| 08/01/2013 | WO2013075105A3 Tcl1 peptides for immunotherapy |
| 08/01/2013 | WO2013055745A3 Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| 08/01/2013 | WO2013055058A3 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 08/01/2013 | WO2011163594A3 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| 08/01/2013 | US20130198875 Rna sequence-specific mediators of rna interference |
| 08/01/2013 | US20130197210 Complexing agents for compositions containing inclusion complexes |
| 08/01/2013 | US20130197194 Spider silk based matrix |
| 08/01/2013 | US20130197188 Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound |
| 08/01/2013 | US20130196930 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/01/2013 | US20130196929 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 08/01/2013 | US20130196925 Compositions and methods useful in enhancement of memory |
| 08/01/2013 | US20130196921 Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| 08/01/2013 | US20130196920 Process for production of bivalirudin |
| 08/01/2013 | US20130196919 Process for production of bivalirudin |
| 08/01/2013 | US20130196918 Process for production of bivalirudin |
| 08/01/2013 | US20130196917 Process for production of bivalirudin |
| 08/01/2013 | US20130196916 Process for production of bivalirudin |
| 08/01/2013 | US20130196914 Methods for Chronic Pain Management and Treatment using HCG |
| 08/01/2013 | US20130196911 Methods and compositions for cardioprotection and cardioregeneration |
| 08/01/2013 | US20130196908 Methods for treatment of pain |
| 08/01/2013 | US20130196907 Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts |
| 08/01/2013 | US20130196905 Use of glycomacropeptide to improve women's health |
| 08/01/2013 | US20130196904 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
| 08/01/2013 | US20130196898 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| 08/01/2013 | US20130196896 Car peptide for homing, diagnosis & targeted therapy for pulmonary and fibrotic disorders |
| 08/01/2013 | US20130196427 Cancer antigen peptides derived from wt1 |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |